Abstract
Major parts of the etiology and pathogenesis of hypertension remain fragmentary and hypothetical. Over the past few years,1–5 investigative attention has focused more and more on the hypothesis of Dah16 that a circulating natriuretic substance might be the culprit of the increase in arterial pressure. This concept proposes that a genetic defect of sodium metabolism causing a discrete positive sodium balance might stimulate secretion of a naturiuretic hormone. Thus, normal sodium balance in the prehypertensive patient could be achieved by continuous high levels of naturiuretic hormone. However, sodium transport inhibition would occur not only along the nephron but in other tissues as wel1.4,7,8 In vascular smooth muscle it would increase the reactivity and tone of arteriolar and venous smooth muscle, thereby elevating arterial pressure and diminishing the venous compliance. Constriction of capacitance vessels would, in turn, shift the total blood volume from the periphery toward the cardiopulmonary area. This expansion of cardiopulmonary volume would further perpetuate the secretion of the sodium transport inhibitor from the hypothalamus (even in the presence of a normal or contracted total blood volume) and a vicious circle would ensue.
Keywords
- Cardiac Output
- Essential Hypertension
- Total Peripheral Resistance
- Total Blood Volume
- Borderline Hypertension
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
F. J. Haddy and H. W. Overbeck, The role of humoral agents in volume expanded hypertension. Life Sci. 19:935–948 (1976).
M. P. Blaustein. Sodium ions, calcium ions, blood pressure regulation, and hypertension: A reassessment and a hypothesis. Am J. Physiol. 232: C165–C173 (1977).
H. E. deWardener, G. A. MacGregor; Dahl’s hypothesis that a saluretic substance may be responsible for a sustained rise in arterial pressure: Its possible role in essential hypertension. Kidney Int. 18: 1–9 (1980).
L. Poston, R. B. Sewell, S. P. Wilkinson et al, Evidence for a circulating sodium transport inhibitor in essential hypertension. Br. Med J. 282: 847–849, (1981)
G. A. MacGregor, S. Fenton, J. Alaghband-Zadeh et al, Evidence for a raised concentration of a circulating sodium transport inhibitor in essential hypertension. Br. Med. J. 283 1355–1357 (1981).
L. K. Dahl, K. D. Knudsen, J. Iwai; Humoral transmission of hypertension. Circulation Res 1 (Suppl. 24/25): 21–31, (1969).
E. Ambrosioni, F. C. Costa, L. Montebugnoli, F. Tartagni, B. Magnani; Increased intralymphocytic sodium content in essential hypertension: An index of impaired Na+ cellular metabolism. Clin Sci 61:181–186, (1981).
P. Meyer, R. P. Garay, Genetic markers in essential hypertension. Clin Exp Hyper 3:4, (1981).
B. Falkner, H. Kushner, B. Onesti, E. T. Anselakos, Cardiovascular characteristics in adolescents who develop essential hypertension. Hypertension 3(5): 521–527, (1981).
W. McCrory, A. A. Klein, R. A. Rosenthal, Blood pressure, heart rate, and plasma catecholamines in normal and hypertensive children and their siblings at rest and after standing. Hypertension 4(4):507–513 (1982)
J. Widimsky, M. D. Fejfarova, Z. Fejfar, Changes in cardiac output in hypertensive disease. Cardiologia 31:381,(1957).
E. D. Frohlich, V. J. Kozul, R. C. Tarazi, H. P. Dustan, Physiological comparison of labile and essential hypertension. Circ Res 27:55, (1970).
R. Sannerstedt, Hemodynamic response to exercise in patients with essential hypertension. Acta Med Scand 180 (suppl 458):1, (1966).
O. Lund-Johansen, Hemodynamics in early essential hypertension. Acta Med Scand 181 (suppl 482): 1, (1967).
M. E. Safar, J. P. Fendler, B. Weil, J. M. Idatte, P. Veauvemayr, P. Milliez, Etude hemodynamique de l’hypertensioin arterielle labile. Presse Med 78:111 (1970).
S. Julius, A. V. Pascual, R. Sannerstedt, C. Mitchell, Relationship between cardiac output and peripheral resistance in borderline hypertension. Circulation 43:382 (1971)
M. E. Ulrych, E. D. Frohlich, R. C. Tarazi, H. P. Dustan, I. H. Page, Cardiac output and distribution of blood volume in central and peripheral circulations in hypertensive and normotensive man. Br Heart J 31:370 (1969).
J. M. Kioschos, W. M. Kirkendall, M. R. Valenca, A. E. Fitz, Unilateral renal hemodynamics and characteristics of dyedilution curves in patients with essential hypertension and renal disease. Circulation 35:229 (1967).
F. H. Messerli, E. D. Frohlich, D. H. Suarez, et al, Borderline hypertension: Relationship between age, hemodynamics and circulating catecholamines. Circulation 64:760–764 (1981)
N. K. Hollenberg, J. P. Merrill, Intrarenal perfusion in the young “essential” hypertensive: A subpopulation resistant to sodium restriction. Trans Assoc Am Physicians 83:93 (1970).
F. H. Messerli, H. O. Ventura, E. Reisin et al, Borderline hypertension and obesity: Two prehypertensive states with elevated cardiac output. Circulation 66: 55–60, (1982).
J. G. R. deCarvalho, F. H. Messerli, E. D. Frohlich, Mitral valve prolapse and borderline hypertension. Hypertension 1:518–522, (1979).
C. N. Ellis, S. Julius, Role of central blood volume in hyperkinetic borderline hypertension. Br Heart J 35:450–455 (1973).
O. Bertel, F. R. Buhler, W. Kiowski, B. E. Lutold, Decreased beta-adrenergic responsiveness as related to age, blood pressure, and plasma catecholamines in patients with essential hypertension. Hypertension 2:180, (1980).
Y. Miura, K. Kobayashi, H. Sakuma, H. Tomioka, M. Adachi, K. Yoshinaga, Plasma noradrenaline concentrations and haemodynamics in the early stage of essential hypertension. Clin Sci and Mol Med, 55 (Suppl. 4): 69s-71s, (1978).
E. D. Frohlich, Hemodynamics of hypertension. In: Jacques Genest, Erick Koiw and Otto Kuchel (eds.) “Hypertension”, New York, McGraw-Hill, (1977).
S. Julius, J. Conway, Hemodynamic studies in patients with borderline blood pressure elevation. Circulation 38: 282–288, (1968).
S. Julius, M. Elser, Autonomic nervous cardiovascular regulation in borderline hypertension. Am J. Cardiol 36: 685–695, (1975).
S. Julius, Abnormalities of autonomic nervous control in borderline hypertension. Schweiziersche Medizinische Wochenschrift, 106: 1698–1705, (1976).
S. Heyden, H. A. Tyroler, C. G. Hames, et al, Diet treatment of obese hypertensives. Clin Sci Mol Med 45:209s, (1973).
W. B. Kannel, N. Brand, J. J. Skinner Jr., T. R. Dawber, P. M. McNamara, The relation of adiposity to blood pressure and development of hypertension. The Framingham study. Ann Intern Med 67:48, (1967).
J. B. Langston, A. C. Guyton, B. H. Douglas, P. E. Dorsett, Effect of changes in salt intake on arterial pressure and renal function in partially nephrectomized dogs. Circ Res 12: 508–513, (1963).
A. W. Cowley Jr., A. C. Guyton, Baroreceptor reflex effects on transient and steady-state hemodynamics of salt-loading hypertension in dogs. Circ Res 36:536–546, (1975).
A. C. Guyton, The relationship of cardiac output and arterial pressure control. Circulation 64:1079–1088, (1981).
Y. A. Weiss, M. E. Safar, G. M. London, A. C. Simon, J. A. Levenson, P. M. Milliez, Repeat hemodynamic determinations in borderline hypertension. Am J Med 64:382, (1978).
A. R. Cournand, L. Riley, E. S. Breed, W. F. Baldwin, D. W. Richards Jr, Measurements of cardiac output in man using the technique of catherization of the right auricle or ventricle. J. Clin Invest 24–106 (1945).
M. Brandfonbrener, M. Landowne, N. W. Shock, Changes in cardiac output with age. Circulation 12:557, (1955).
R. C. Tarazi, E. D. Frohlich, H. P. Dustan. Plasma volume in man with essential hypertension. N Engl J Med 278:762–765, (1968).
C. R. Lake, M. G. Ziegler, M. D. Coleman, I. J. Kopin, Ageadjusted plasma norepinephrine levels are similar in normotensive and hypertensive subjects. N Engl J Med 296:298, (1977).
E. D. Frohlich, R. C. Tarazi, H. P. Dustan. Reexamination of the hemodynamics of hypertension. Am J Med Sc 257:9–23, (1969).
R. Sannerstedt, Differences in haemodynamic pattern in various types of hypertension. Triangle 9:293–299, (1970).
P. Lund-Johansen, Haemodynamics in essential hypertension. Clin Sci 59:343s–354s, (1980).
F. C. Reubi, P. Weidmann, J. Hodler, P. T. Cottier, Changes in renal function in essential hypertension. Am J Med 64(4): 556–563, (1978).
M. Friedman, A. Selzer, H. Rosenblum, The renal blood flow in hypertension as determined in patients with variable, with early and long-standing hypertension. JAMA 17: 92–95, (1941).
F. H. Messerli, K. Sundgaard-Rise, E. Reisin, et al, Disparate cardiovascular obesity and arterial hypertension. Am J Med 1882 (in press).
F. H. Messerli, Cardiovascular effects of obesity and hypertension. Lancet 1167–1168, (1982).
O. Divitis, S. Fazio, M. Petitto, G. Maddalena, F. Contaldo, M. Mancini, Obesity and cardiac function. Circulation 64:447–482. (1981).
G. A. Perera, A. Damon, Height, weight, and their ratio in the accelerated form of primary hypertension. Arch Int Med 100:263–265, (1957).
J. K. Alexander, J. R. Pettigrove, Obesity and congestive heart failure. Geriatrics 22:101–106, (1967).
T. Gordon, W. B. Kannel. Obesity and cardiovascular disease: the Framingham Study. Clin Endocrinol Metabol 5:367–374, (1976).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1984 Springer Science+Business Media New York
About this chapter
Cite this chapter
Messerli, F.H., Frohlich, E.D. (1984). Pathogenetic Mechanisms in Essential Hypertension. In: Chazov, E.I., Smirnov, V.N., Oganov, R.G. (eds) Cardiology. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-1824-9_27
Download citation
DOI: https://doi.org/10.1007/978-1-4757-1824-9_27
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-1826-3
Online ISBN: 978-1-4757-1824-9
eBook Packages: Springer Book Archive